FindTrial
Sign In

The Role of Pharmacist-Led Interventions in the Early Detection of Adverse Drug Reactions among People with Dementia and Their Families: A Scoping Review

The Role of Pharmacist-Led Interventions in the Early Detection of Adverse Drug Reactions among People with Dementia and Their Families: A Scoping Review - The Role of Pharmacist-Led Interventions in the Early Detection of Adverse Drug Reactions among People with Dementia and Their Families: A Scoping Review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000060253
Enrollment
Unknown
Registered
2026-01-05
Start date
2025-11-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia (including Alzheimer&#39

Interventions

None listed

Sponsors

Tokyo University of Pharmacy and Life Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Population: people with dementia and their families or caregivers Concept: pharmacist involvement (consultation and support) with potential contribution to early detection of adverse drug reactions Context: medication support settings in the community, including outpatient and home-based care

Exclusion criteria

Exclusion criteria: Research using languages other than Japanese or English. Excluding review articles, commentaries, and conference proceedings.

Design outcomes

Primary

MeasureTime frame
We analysed studies examining the contribution of pharmacist-led interventions to the early detection of adverse drug reactions in people with dementia and their families.—

Countries

Japan

Contacts

Public ContactTakenori Ichimura

Tokyo University of Pharmacy and Life Sciences Center for Experimental Pharmacy Practice, School of Pharmacy

ichimura@toyaku.ac.jp042-676-5189

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026